On May 15, Jiangxi RIMAG Group Co., Ltd. (HKEX: 2522) (“RIMAG”) and Hong Kong’s EC Healthcare (HKEX: 2138) (“EC Healthcare”), held a grand strategic cooperation signing ceremony in Hong Kong. The two parties officially launched the “RIMAG-EC Health Tech Alliance” and announced plans to jointly build a “dual-engine supply chain platform” centered on “Centralized Procurement + Global Distribution.” This collaboration not only marks a powerful synergy between industry leaders but also signifies a milestone in Chinese medical services’ global expansion, injecting fresh momentum into the efficient integration and coordinated development of worldwide healthcare resources.

Complementary Strengths, Building a Strategic Ecosystem

As China’s top third-party medical imaging group, RIMAG specializes in the full medical imaging industry chain, covering imaging center operations, equipment management, cloud platform services, and talent development. It serves over 20,000 patients daily across 16 provinces nationwide. EC Healthcare, the largest non-hospital healthcare service provider in Hong Kong, operates 171 service points under 44 diversified brands, offering a one-stop health ecosystem that spans precision medicine, health management, and aesthetic medicine.

Leveraging their “complementary DNA and resource synergies,” the two companies will establish a joint venture to integrate RIMAG’s expertise in medical imaging equipment, consumables supply chains, and departmental operations with EC Healthcare’s established channels in Hong Kong, Macau, and overseas markets. This partnership aims to create a global medical technology supply chain platform, providing efficient pathways for high-quality Chinese medical products to expand internationally while supporting EC Healthcare’s brands with centralized procurement solutions. The alliance will enable “Chinese services and technologies” to empower global markets and vice versa.

Dual-Engine Strategy, Accelerating Global Reach

The collaboration’s core lies in its “Centralized Procurement + Global Distribution” model, designed to foster a cohesive global medical tech ecosystem. By harnessing RIMAG’s resource integration capabilities in medical consumables, imaging equipment, and operational management, the joint venture will enhance supply chain efficiency for EC Healthcare’s medical institutions, offering standardized services, equipment installation, IT platform development, and lifecycle maintenance. Simultaneously, EC Healthcare’s mature distribution networks and brand influence in Hong Kong, Macau, and Southeast Asia will open international pathways for Chinese medical innovations, propelling domestic technologies and services onto the global stage. The partnership will also drive operational innovation through academic training, remote diagnostics, and smart management systems, elevating healthcare service quality and efficiency worldwide.

Innovating Global Expansion, Shaping Healthcare’s Future

At the signing ceremony, Mr. Eddy Tang, Founder, Chairman, and Executive Director of EC Healthcare, stated, “This alliance is a strategic leap for EC Healthcare and a bridge connecting Hong Kong’s medical sector to global resources. Through centralized procurement, we can swiftly access premium equipment and consumables, optimize costs, and improve service agility. We are committed to delivering cutting-edge medical technologies to patients through this platform.”

Mr. Chen Zhaoyang, Chairman, CEO, and Executive Director of RIMAG, emphasized, “The joint venture will serve as a global hub for distributing China’s medical imaging services and tech products. Drawing on our experience managing over 100 imaging centers, we will curate high-quality consumables and data-driven solutions, leveraging EC Healthcare’s international networks to bring cost-effective imaging services and unparalleled data experiences to the world.”

This strategic alliance represents a pivotal step for Chinese medical imaging enterprises transitioning from local dominance to global influence. RIMAG and EC Healthcare will use this partnership as a springboard, fuelled by innovation and resource synergy, to deepen international cooperation and integrate Chinese medical technologies into global markets. Moving forward, the two aim to cultivate an open, inclusive, and mutually beneficial medical tech ecosystem, transcending borders to make premium healthcare resources accessible worldwide. Together, they will contribute “Chinese solutions” to building a shared future for global health.